Tech Center 1600 • Art Units: 1617 1655
This examiner grants 75% of resolved cases
Robert Franklin Spaine examines applications in Tech Center 1600 and Art Unit 1617. With only 8 resolved cases, the data pool is limited but shows a high allowance rate of 75.0%. This rate suggests a favorable outlook for applicants, although the median days to allowance of 1014 indicates that the process still requires significant time. The small number of resolutions means that individual case outcomes have a large impact on these percentages.
The interview lift of 0.0% is a critical data point. It indicates that interviews have not historically improved the 75.0% allowance rate for this examiner. For practitioners, this suggests that written arguments or amendments might be more effective than verbal consultations when navigating Art Unit 1617. The 1014 days to allowance remains the primary benchmark for timeline expectations in these 8 resolved cases. Given the 75.0% allowance rate, the lack of lift suggests that cases are typically allowed on their merits or rejected despite verbal discussion. Applicants should prioritize clear written advocacy to maintain the high probability of success.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18580411 | COMPOSITIONS COMPRISING CONSTITUENTS, DERIVATIVES OR EXTRACTS OF CANNABIS | Final Rejection | Nicoventures Trading Limited |
| 18730928 | COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE, COMPRISING EXTRACELLULAR VESICLES DERIVED FROM ROSEBURIA SPP. OR BIFIDOBACTERIUM SPP. | Non-Final OA | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18705307 | COMPOSITIONS SUITABLE FOR USE IN SKIN CARE | Non-Final OA | JOHNSON & JOHNSON CONSUMER INC. |
| 18610473 | MELTING MASSAGE BAR | Non-Final OA | Johnson & Johnson Consumer Inc. |
| 18694586 | FILLER COMPOSITION FOR REDUCING SKIN WRINKLES COMPRISING STEM CELL-DERIVED EXOSOMES, HYALURONIC ACID, AND BDDE AND METHOD FOR PREPARING SAME | Final Rejection | RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY |
| 18706991 | STEM CELL PROLIFERATION PROMOTER | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 18688795 | Prunella vulgaris extract and use thereof | Non-Final OA | Clariant International Ltd |
| 18705256 | COMPOSITION FROM ARONIA MELANOCARPA | Non-Final OA | GIVAUDAN SA |
| 18352677 | COMPOSITIONS CONTAINING KRATOM COMPOUNDS | Non-Final OA | CAAMTECH, INC. |
| 17795389 | PROCESS FOR OBTAINING AN AQUEOUS EXTRACT OF LAVENDER, COMPOSITIONS COMPRISING SUCH AN EXTRACT, AND THEIR COSMETIC USES | Final Rejection | ISP INVESTMENTS LLC. |
| 18409817 | METHODS FOR IMPROVING SLEEP QUALITY, INCREASING MITOCHONDRIAL EXPRESSION, PROMOTING CELL REPAIRING, OR FIRMING SKIN BY USING SPARASSIA CRISPA EXTRACT | Final Rejection | TCI CO., LTD. |
| 18528783 | METHODS FOR RESISTING SKIN AGING BY USING KIWIBERRY EXTRACT | Non-Final OA | TCI CO., LTD. |
| 18560734 | COSMETIC COMPOSITION, USE OF CASEARIA SYLVESTRIS, SCHINUS TEREBINTHIFOLIUS, HYMENAEA COURBARIL AND LACTOBACILLUS AND METHOD FOR THE PREVENTION AND/OR TREATMENT OF SIGNS RESULTING FROM SKIN AGING | Final Rejection | Natura Cosméticos S.A. |
| 18164368 | METHODS AND COMPOSITIONS FOR UPREGULATING RNA INTERFERENCE AND ENHANCING GENE SILENCING | Non-Final OA | GOWEY RESEARCH GROUP, PLLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy